Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Bajetta

Showing results (121-130 of 212) with videos related to

Pageof 22
Sort By:
European Journal of Cancer (Oxford, England : 1990)|December 1, 1995
Oral chemotherapy with doxifluridine and folinic acid in biliary tract cancerM Colleoni, M Di Bartolomeo, A Di Leo, et al.
British Journal of Cancer|March 31, 2011
Sorafenib with interleukin-2 vs sorafenib alone in metastatic renal cell carcinoma: the ROSORC trialG Procopio, E Verzoni, S Bracarda, et al.
Tumori|September 1, 1974
[Adriamycin in combination and in combined treatment modalities (author's transl)]G Bonadonna, G Beretta, G Tancini, et al.
Journal of Cancer Research and Clinical Oncology|January 1, 1995
Formestane: an effective first-line endocrine treatment for advanced breast cancerN Zilembo, E Bajetta, C Noberasco, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1994
Formestane: effective therapy in postmenopausal women with advanced breast cancerE Bajetta, N Zilembo, R Buzzoni, et al.
Cancer|February 15, 1986
A clinical study of the pineal gland activity in oncologic patientsP Lissoni, S Viviani, E Bajetta, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1993
Prospective randomised trial comparing fluorouracil versus doxifluridine for the treatment of advanced colorectal cancerE Bajetta, M Colleoni, R Rosso, et al.
European Journal of Cancer (Oxford, England : 1990)|April 1, 1997
Doxifluridine in colorectal cancer patients resistant to 5-fluorouracil (5-FU) containing regimensE Bajetta, M Di Bartolomeo, L Somma, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 14, 1998
Pilot study of subcutaneous recombinant human interleukin 12 in metastatic melanomaE Bajetta, M Del Vecchio, R Mortarini, et al.
British Journal of Cancer|May 1, 1994
The intramuscular administration of granulocyte colony-stimulating factor as an adjunct to chemotherapy in pretreated ovarian cancer patients: an Italian Trials in Medical Oncology (ITMO) Group pilot studyA Di Leo, E Bajetta, F Nolè, et al.
Pageof 22

Showing results (121-130 of 212) with videos related to

Sort By:
Pageof 22
European Journal of Cancer (Oxford, England : 1990)|December 1, 1995
Oral chemotherapy with doxifluridine and folinic acid in biliary tract cancerM Colleoni, M Di Bartolomeo, A Di Leo, et al.
British Journal of Cancer|March 31, 2011
Sorafenib with interleukin-2 vs sorafenib alone in metastatic renal cell carcinoma: the ROSORC trialG Procopio, E Verzoni, S Bracarda, et al.
Tumori|September 1, 1974
[Adriamycin in combination and in combined treatment modalities (author's transl)]G Bonadonna, G Beretta, G Tancini, et al.
Journal of Cancer Research and Clinical Oncology|January 1, 1995
Formestane: an effective first-line endocrine treatment for advanced breast cancerN Zilembo, E Bajetta, C Noberasco, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1994
Formestane: effective therapy in postmenopausal women with advanced breast cancerE Bajetta, N Zilembo, R Buzzoni, et al.
Cancer|February 15, 1986
A clinical study of the pineal gland activity in oncologic patientsP Lissoni, S Viviani, E Bajetta, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1993
Prospective randomised trial comparing fluorouracil versus doxifluridine for the treatment of advanced colorectal cancerE Bajetta, M Colleoni, R Rosso, et al.
European Journal of Cancer (Oxford, England : 1990)|April 1, 1997
Doxifluridine in colorectal cancer patients resistant to 5-fluorouracil (5-FU) containing regimensE Bajetta, M Di Bartolomeo, L Somma, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 14, 1998
Pilot study of subcutaneous recombinant human interleukin 12 in metastatic melanomaE Bajetta, M Del Vecchio, R Mortarini, et al.
British Journal of Cancer|May 1, 1994
The intramuscular administration of granulocyte colony-stimulating factor as an adjunct to chemotherapy in pretreated ovarian cancer patients: an Italian Trials in Medical Oncology (ITMO) Group pilot studyA Di Leo, E Bajetta, F Nolè, et al.
Pageof 22